FERMT2 and colorectal carcinoma: It is indicated that the expression of FERMT2 at mRNA level in colon carcinoma, colon adenocarcinoma, colorectal carcinoma and colon carcinoma epithelia were increased significantly than that of control tissues from several datasets (Fig 1A–1E and Table 1).